» Articles » PMID: 33476007

Functional Imaging Using Fluorine (F) MR Methods: Basic Concepts

Overview
Specialty Molecular Biology
Date 2021 Jan 21
PMID 33476007
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Kidney-associated pathologies would greatly benefit from noninvasive and robust methods that can objectively quantify changes in renal function. In the past years there has been a growing incentive to develop new applications for fluorine (F) MRI in biomedical research to study functional changes during disease states. F MRI represents an instrumental tool for the quantification of exogenous F substances in vivo. One of the major benefits of F MRI is that fluorine in its organic form is absent in eukaryotic cells. Therefore, the introduction of exogenous F signals in vivo will yield background-free images, thus providing highly selective detection with absolute specificity in vivo. Here we introduce the concept of F MRI, describe existing challenges, especially those pertaining to signal sensitivity, and give an overview of preclinical applications to illustrate the utility and applicability of this technique for measuring renal function in animal models.This chapter is based upon work from the COST Action PARENCHIMA, a community-driven network funded by the European Cooperation in Science and Technology (COST) program of the European Union, which aims to improve the reproducibility and standardization of renal MRI biomarkers. This introduction chapter is complemented by two separate chapters describing the experimental procedure and data analysis.

Citing Articles

How to 19F MRI: applications, technique, and getting started.

Maxouri O, Bodalal Z, Daal M, Rostami S, Rodriguez I, Akkari L BJR Open. 2023; 5(1):20230019.

PMID: 37953866 PMC: 10636348. DOI: 10.1259/bjro.20230019.


Molecular MRI-Based Monitoring of Cancer Immunotherapy Treatment Response.

Vladimirov N, Perlman O Int J Mol Sci. 2023; 24(4).

PMID: 36834563 PMC: 9959624. DOI: 10.3390/ijms24043151.


F MRI Nanotheranostics for Cancer Management: Progress and Prospects.

Li Y, Cui J, Li C, Zhou H, Chang J, Aras O ChemMedChem. 2021; 17(4):e202100701.

PMID: 34951121 PMC: 9432482. DOI: 10.1002/cmdc.202100701.

References
1.
Jiang Z, Liu X, Jeong E, Yu Y . Symmetry-guided design and fluorous synthesis of a stable and rapidly excreted imaging tracer for (19)F MRI. Angew Chem Int Ed Engl. 2009; 48(26):4755-8. PMC: 2873849. DOI: 10.1002/anie.200901005. View

2.
Ten Brinke A, Hilkens C, Cools N, Geissler E, Hutchinson J, Lombardi G . Clinical Use of Tolerogenic Dendritic Cells-Harmonization Approach in European Collaborative Effort. Mediators Inflamm. 2016; 2015:471719. PMC: 4706930. DOI: 10.1155/2015/471719. View

3.
Hu L, Zhang L, Chen J, Lanza G, Wickline S . Diffusional mechanisms augment the fluorine MR relaxation in paramagnetic perfluorocarbon nanoparticles that provides a "relaxation switch" for detecting cellular endosomal activation. J Magn Reson Imaging. 2011; 34(3):653-61. PMC: 3197905. DOI: 10.1002/jmri.22656. View

4.
Vernikouskaya I, Pochert A, Linden M, Rasche V . Quantitative F MRI of perfluoro-15-crown-5-ether using uniformity correction of the spin excitation and signal reception. MAGMA. 2018; 32(1):25-36. DOI: 10.1007/s10334-018-0696-6. View

5.
Schmieder A, Caruthers S, Keupp J, Wickline S, Lanza G . Recent Advances in Fluorine Magnetic Resonance Imaging with Perfluorocarbon Emulsions. Engineering (Beijing). 2016; 1(4):475-489. PMC: 4841681. DOI: 10.15302/J-ENG-2015103. View